Abbas Haidy, El-Deeb Nehal M, Zewail Mariam
Pharmaceutics Department, Faculty of Pharmacy, Damanhour University, Damanhur, Egypt.
Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, New Borg El-Arab City, Egypt.
Pharm Dev Technol. 2021 Jul;26(6):682-692. doi: 10.1080/10837450.2021.1920617. Epub 2021 May 6.
Although there are several treatments for rheumatoid arthritis (RA), outcomes are unsatisfactory and often associated with many side effects. We attempted to improve RA therapeutic outcomes by intra-articular administration of dual drug-loaded poly(lactic) acid (PLA)-coated herbal colloidal carriers (HCCs). Curcumin (CU) and resveratrol (RES) were loaded into HCCs because of their safety and significant anti-inflammatory activity. HCCs were prepared using a high-pressure, hot homogenization technique and evaluated and using a complete Freund's adjuvant-induced arthritis model. Transmission electron microscope (TEM) evaluated coating selected formulations with PLA, which increased particle sizes from 52 to 89.14 nm. The entrapment efficiency of both formulations was approximately 76%. HCCs significantly increased the amount of RES and CU released compared with the drug suspensions alone. The treated groups showed a significant improvement in joint healing. PLA-coated HCCs, followed by uncoated HCCs, yielded the highest reductions in knee diameter, myeloperoxidase (MPO) levels, and tumor necrosis factor-alpha (TNFα) levels. Histological examination of the dissected joints revealed that PLA-coated HCCs followed by uncoated HCCs exhibited the most significant joint healing effects. Our results demonstrate the superiority of intra-articularly administered HCCs to suppress RA progression compared with RES or CU suspensions alone.
尽管类风湿性关节炎(RA)有多种治疗方法,但治疗效果并不理想,且常常伴有许多副作用。我们试图通过关节腔内注射载有两种药物的聚乳酸(PLA)包被的草药胶体载体(HCCs)来改善RA的治疗效果。姜黄素(CU)和白藜芦醇(RES)因其安全性和显著的抗炎活性而被载入HCCs。采用高压热均质技术制备HCCs,并使用完全弗氏佐剂诱导的关节炎模型进行评估。透射电子显微镜(TEM)评估了用PLA包被的选定制剂,其使粒径从52纳米增加到89.14纳米。两种制剂的包封率均约为76%。与单独的药物悬浮液相比,HCCs显著增加了RES和CU的释放量。治疗组的关节愈合情况有显著改善。PLA包被的HCCs,其次是未包被的HCCs,使膝关节直径、髓过氧化物酶(MPO)水平和肿瘤坏死因子-α(TNFα)水平降低得最多。对解剖后的关节进行组织学检查发现,PLA包被的HCCs其次是未包被的HCCs表现出最显著的关节愈合效果。我们的结果表明,与单独的RES或CU悬浮液相比,关节腔内注射HCCs在抑制RA进展方面具有优越性。